VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AKBA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AKBAAkebia Therapeutics, Inc.
$0.40$108M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAKBADividend History

AKBA logoAkebia Therapeutics, Inc. (AKBA) Dividend History

Income profile from 2012 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

AKBA Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

0 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

AKBA Dividend Scorecard

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9

Growth

Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return-80.0%
5Y Total Return-86.0%
Estimated $10K growth (return + dividends):
5Y ago$1,39810Y ago$51220Y ago$150

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). AKBA's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.

AKBA Dividend History

No dividend payment history available

This company has not paid dividends during the available data period.

Get AKBA's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Akebia Therapeutics, Inc. has limited earnings payout data (Unknown).

Piotroski F-Score: 5/9 — moderate financial health.

Growth Track Record

AKBA does not have a current streak of consecutive dividend increases.

Total Shareholder Returns

Beyond cash dividends, AKBA returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.

Income Trend & Total Return

The 5-year total return is -86.0%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $512 today.

AKBA Dividend vs Peers

Comparable companies in the same industry

Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
0.0%
#5 of 5
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
AKBA logoAKBAAkebia Therapeutics,…
$108M———0—0.0%0.0%-80.0%Unknown
ANIP logoANIPANI Pharmaceuticals,…
$1.5B0.1%—0.6%0—0.8%0.9%-25.3%Unknown
3rd
FXNC logoFXNCFirst National Corpo…
$275M2.0%31.2%26.8%119.1%0.1%2.1%35.5%Sustainable
1st
GSK logoGSKGSK plc
$100.8B3.2%43.9%35.9%2-2.7%0.0%3.2%10.7%Sustainable
2nd
AMGN logoAMGNAmgen Inc.
$248.5B2.1%66.5%53.3%158.3%0.0%2.1%49.0%Watch

AKBA Annual Dividend History (2012–2025)

14 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$-0.02——$0.26—0.0%0.0%—
2024$0.00—0$-0.33——$-0.19—0.3%0.3%—
2023$0.00—0$-0.28——$-0.12—0.0%0.0%—
2022$0.00—0$-0.58——$-0.40—0.0%0.0%—
2021$0.00—0$-1.48——$-1.52—0.0%0.0%—
2020$0.00—0$-2.53——$-0.80—0.0%0.0%—
2019$0.00—0$-2.36——$-2.23—0.1%0.1%—
2018$0.00—0$-1.47——$-0.85—0.0%0.0%—
2017$0.00—0$-1.77——$-1.33—0.0%0.0%—
2016$0.00—0$-3.60——$1.46—0.0%0.0%—
Consensus & Technical Research Suite
Open AKBA Terminal

AKBA Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

14+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AKBA — Frequently Asked Questions

Quick answers to the most common questions about buying AKBA stock.

How much dividend does AKBA pay per share?

Akebia Therapeutics, Inc. (AKBA) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.

When is AKBA's next ex-dividend date?

AKBA's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. AKBA typically pays dividends quarterly.

Is AKBA's dividend safe?

AKBA's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.

How many years has AKBA increased its dividend?

AKBA has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.

How often does AKBA pay dividends?

Akebia Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 13+ years from 2012 to 2025.

How much would $10,000 invested in AKBA grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in AKBA five years ago would be worth approximately $1,398 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is AKBA's yield on cost for long-term holders?

AKBA's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.